Ozes et al. [101] revealed that overexpression of HOTAIR blocked the binding of HOTAIR to EZH2, thereby decreasing tumor invasion and increasing chemotherapy sensitivity in breast and ovarian cancer cells. The gene discussed is HOTAIR; the disease is ovarian carcinoma.